MarketPeel
Insider Trading Intelligence
DA

Daniel Joseph Apel

ARWR
CHIEF FINANCIAL OFFICER · ARROWHEAD PHARMACEUTICALS, INC. · CIK 0002081169
FILING MIX · LIFETIME25%/75%
BUYS
1
SELLS
3
TOTAL VALUE
$934.3K
COMPANIES
1
ACTIVE SINCE
Jan 2026
HOLDINGS NOW
172,792
AVG SELL PX
$71.35
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Daniel Joseph Apel, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%-4.59%+0.05%-4.64%-4.64%
14d3+0.00%+7.06%+3.18%+3.88%+3.88%
30d3+0.00%+2.95%
60d3+0.00%+10.69%+5.00%+5.69%+5.69%
90d3(3 pending)
180d3(3 pending)
1y3(3 pending)
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARWR · 172,792 shares · as of Apr 22, 2026
044,05088,100132,150176,200SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 1 buys / 3 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
1,157$70.45$81.5K171,635Apr 22, 2026Apr 24, 2026View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,730$71.92$627.9K162,905Apr 22, 2026Apr 24, 2026View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,208$70.11$224.9K172,792Apr 22, 2026Apr 24, 2026View →
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
75,000176,200Jan 6, 2026Jan 8, 2026View →
Other insiders · ARWR
Loading peer insiders…
About this filer
CIK 0002081169
ROLE
Chief Financial Officer
PRIMARY
ARWR
COMPANIES
1
ACTIVE SINCE
Jan 2026
MARKETPEEL · /INSIDER/0002081169DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback